Abstract
This study investigated whether women with cardiovascular disease (CVD) would have an increased risk of fractures as osteoporosis and CVD share many common risk factors. From February 2006 to January 2007, 17,033 women aged ≥50 years (mean 71.8, range 50–106) were recruited by 1,248 primary care practitioners and interviewed by trained nurses. For each woman, 10-year probability of a future major osteoporotic fracture was estimated using the World Health Organization Fracture Risk Assessment Tool (FRAX). The study showed that the 10-year probability of a major osteoporotic fracture was higher for 6,219 CVD women compared to 10,814 non-CVD women after adjustment for age, BMI, current smoking, and alcohol use (adjusted geometric means 14.3 and 13.8%, respectively; P < 0.001). With regard to high risk of fracture (i.e., 10-year probability ≥ 20%), the adjusted odds ratio for CVD was 1.23 (95% CI 1.13–1.35, P < 0.001). However, compared to non-CVD women, CVD women were more likely to report a previous fracture, to have a secondary osteoporosis, and to use glucocorticoids. Among the 4,678 women who were classified as having a high fracture risk, current use rate of bone-related medications (i.e., any one of bisphosphonates, raloxifene, PTH, vitamin D, calcium, or hormone therapy) was 50.2% in the CVD group and 56.9% in the non-CVD group. Women with CVD were at increased risk of fracture partly due to bone-specific risk factors such as history of previous fracture, use of glucocorticoids, and secondary osteoporosis. This risk is not being treated appropriately by primary health physicians.
Similar content being viewed by others
References
Murray CJ, Lopez AD (1997) Alternative projections of mortality and disability by cause 1990–2020: Global Burden of Disease Study. Lancet 349:1498–1504
Cooper C, Campion G, Melton LJ III (1992) Hip fractures in the elderly: a world-wide projection. Osteoporos Int 2:285–289
Begg S, Vos T, Barker B, Stevenson C, Stanley L, Lopez A (2007) The burden of disease and injury in Australia 2003. Australian Institute of Health and Welfare, Canberra
Osteoporosis consensus statement, Australia (1997) Med J Aust. http://www.mja.com.au/public/guides/osteo/whatis.html
Cumming RG, Nevitt MC, Cummings SR (1997) Epidemiology of hip fractures. Epidemiol Rev 19:244–257
Giardina EG (2000) Heart disease in women. Int J Fertil Womens Med 45:350–357
McFarlane SI, Muniyappa R, Shin JJ, Bahtiyar G, Sowers JR (2004) Osteoporosis and cardiovascular disease: brittle bones and boned arteries, is there a link? Endocrine 23:1–10
NIAMS-NHLBI Working Group (1999) New evidence connecting cardiovascular disease and osteoporosis. www.nhlbi.nih.gov/meetings/workshops/bnhrtsm.htm
Warburton DE, Nicol CW, Gatto SN, Bredin SS (2007) Cardiovascular disease and osteoporosis: balancing risk management. Vasc Health Risk Manag 3:673–689
Hyder JA, Allison MA, Wong N, Papa A, Lang TF, Sirlin C, Gapstur SM, Ouyang P, Carr JJ, Criqui MH (2009) Association of coronary artery and aortic calcium with lumbar bone density: the MESA Abdominal Aortic Calcium Study. Am J Epidemiol 169:186–194
Kiel DP, Kauppila LI, Cupples LA, Hannan MT, O’Donnell CJ, Wilson PW (2001) Bone loss and the progression of abdominal aortic calcification over a 25 year period: the Framingham Heart Study. Calcif Tissue Int 68:271–276
Jorgensen L, Singh K, Berntsen GK, Jacobsen BK (2004) A population-based study of the prevalence of abdominal aortic aneurysms in relation to bone mineral density: the Tromso study. Am J Epidemiol 159:945–949
Bagger YZ, Rasmussen HB, Alexandersen P, Werge T, Christiansen C, Tanko LB (2007) Links between cardiovascular disease and osteoporosis in postmenopausal women: serum lipids or atherosclerosis per se? Osteoporos Int 18:505–512
Browner WS, Pressman AR, Nevitt MC, Cauley JA, Cummings SR (1993) Association between low bone density and stroke in elderly women. The study of osteoporotic fractures. Stroke 24:940–946
Von der Recke P, Hansen MA, Hassager C (1999) The association between low bone mass at the menopause and cardiovascular mortality. Am J Med 106:273–278
Carbone L, Buzkova P, Fink HA, Lee JS, Chen Z, Ahmed A, Parashar S, Robbins JR (2010) Hip fractures and heart failure: findings from the Cardiovascular Health Study. Eur Heart J 31:77–84
Sennerby U, Melhus H, Gedeborg R, Byberg L, Garmo H, Ahlbom A, Pedersen NL, Michaelsson K (2009) Cardiovascular diseases and risk of hip fracture. JAMA 302:1666–1673
van Diepen S, Majumdar SR, Bakal JA, McAlister FA, Ezekowitz JA (2008) Heart failure is a risk factor for orthopedic fracture: a population-based analysis of 16, 294 patients. Circulation 118:1946–1952
Lyles KW, Colon-Emeric CS, Magaziner JS, Adachi JD, Pieper CF, Mautalen C, Hyldstrup L, Recknor C, Nordsletten L, Moore KA, Lavecchia C, Zhang J, Mesenbrink P, Hodgson PK, Abrams K, Orloff JJ, Horowitz Z, Eriksen EF, Boonen S (2007) Zoledronic acid in reducing clinical fracture and mortality after hip fracture. N Engl J Med 357:1799–1809
Colon-Emeric CS, Mesenbrink P, Lyles KW, Pieper CF, Boonen S, Delmas P et al (2008) Potential mediators of the reduction in mortality with zoledronic acid after hip fracture. J Bone Miner Res 23:S10 abstract 1030
Kanis JA, Johnell O, Oden A, Johansson H, McCloskey E (2008) FRAX and the assessment of fracture probability in men and women from the UK. Osteoporos Int 19:385–397
World Health Organization (2007) Assessment of osteoporosis at the primary health care level. WHO, Geneva. http://www.who.int/chp/topics/rheumatic/en/index.html
Chen JS, Hogan C, Lyubomirsky G, Sambrook PN (2009) Management of osteoporosis in primary care in Australia. Osteoporos Int 20:491–496
Garvan Institute. Fracture risk calculator. http://garvan.org.au/promotions/bone-fracture-risk/calculator. Accessed 2 Mar 2010
Orozco P (2004) Atherogenic lipid profile and elevated lipoprotein (a) are associated with lower bone mineral density in early postmenopausal overweight women. Eur J Epidemiol 19:1105–1112
Tanko LB, Bagger YZ, Nielsen SB, Christiansen C (2003) Does serum cholesterol contribute to vertebral bone loss in postmenopausal women? Bone 32:8–14
Meier CR, Schlienger RG, Kraenzlin ME, Schlegel B, Jick H (2000) Statin drugs and the risk of fracture. JAMA 284:1921–1922
Mundy GR (2001) Statins and their potential for osteoporosis. Bone 29:495–497
Sholter DE, Armstrong PW (2000) Adverse effects of corticosteroids on the cardiovascular system. Can J Cardiol 16:505–511
Souverein PC, Berard A, Van Staa TP, Cooper C, Egberts AC, Leufkens HG, Walker BR (2004) Use of oral glucocorticoids and risk of cardiovascular and cerebrovascular disease in a population based case-control study. Heart 90:859–865
Sambrook PN (2005) How to prevent steroid induced osteoporosis. Ann Rheum Dis 64:176–178
Acknowledgement
This study was supported by a research grant from Osteoporosis Australia.
Author information
Authors and Affiliations
Corresponding author
Additional information
Sambrook and Hogan have served on the advisory board and have received speaker fees from Merck. Lyubomirsky is a director of Merck Sharp & Dohme-Asia Pacific. Chen has stated no conflict of interest.
Rights and permissions
About this article
Cite this article
Chen, J.S., Hogan, C., Lyubomirsky, G. et al. Women with Cardiovascular Disease Have Increased Risk of Osteoporotic Fracture. Calcif Tissue Int 88, 9–15 (2011). https://doi.org/10.1007/s00223-010-9431-7
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00223-010-9431-7